✦ LIBER ✦

A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma

✍ Scribed by Kristopher J. Kimball; T. Michael Numnum; Tyler O. Kirby; William C. Zamboni; Jacob M. Estes; Mack N. Barnes; Daniela E. Matei; Kevin M. Koch; Ronald D. Alvarez

Book ID: 113961691
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 194 KB
Volume: 111
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.07.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of gemcitabine plus car

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

✍ M.F. Kose; J. Sufliarsky; S. Beslija; P. Saip; G. Tulunay; K. Krejcy; T. Minarik 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A Phase I/II Study of Topotecan in Combi

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

✍ Giorgio Bolis; Giovanna Scarfone; Cesarina Sciatta; Gian Piero Polverino; Cristi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

Hyperthermic intraperitoneal chemotherap

Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: A pilot study

✍ Argenta, Peter A.; Sueblinvong, Thanasak; Geller, Melissa A.; Jonson, Amy L.; Do 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase 1 and pharmacodynamic study of d

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

✍ Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract ## BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian c

Randomized phase II trial of sorafenib a

Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer

✍ Schwandt, Anita; Gruenigen, Vivian E.; Wenham, Robert M.; Frasure, Heidi; Eaton, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 374 KB